SCHEMBL23239642

SCHEMBL23239642

c1ccc(-c2cccc(-c3ccc(N(c4ccc(-c5ccc6oc7ccccc7c6c5)cc4)c4cccc(-c5cccc(-c6cccc7ccccc67)c5)c4)cc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.40
▸ PLA2G4A P47712 4/20 0.40
▸ PLA2G10 O15496 1/20 0.40
▸ MCL1 Q07820 1/20 0.39
▸ ACMSD Q8TDX5 1/20 0.39
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ ALOX5 P09917 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.35
▸ MAPT P10636 4/20 0.35
▸ HPGD P15428 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ TSHR P16473 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23239396 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL23237213 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL23238863 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL23238845 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL23237304 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL23224454 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL23238801 1.00 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL25824467 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL23239151 0.99 CA12 (0.39) PLA2G2APLA2G4APLA2G10MCL1ACMSD
SCHEMBL10110189 0.99 CA12 (0.39) PLA2G2APLA2G4APLA2G10MCL1ACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
WO-2021070964-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, ELAVL1 PLA2G2A 4217/4885PLA2G4A 4594/4885PLA2G10 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback